fluocinonide has been researched along with Telangiectasis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gans, EH; Kligman, AM; Sadiq, I; Stoudemayer, M; Stoudemayer, T | 1 |
Chalker, DK; Smith, JG; Wehr, RF | 1 |
1 trial(s) available for fluocinonide and Telangiectasis
Article | Year |
---|---|
In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle.
Topics: Administration, Cutaneous; Adult; Atrophy; Clobetasol; Dose-Response Relationship, Drug; Emollients; Erythema; Female; Fluocinonide; Glucocorticoids; Humans; Middle Aged; Severity of Illness Index; Skin; Skin Diseases; Telangiectasis; Water Loss, Insensible | 2008 |
1 other study(ies) available for fluocinonide and Telangiectasis
Article | Year |
---|---|
Corticosteroid-induced cutaneous atrophy and telangiectasia. Experimental production associated with weight loss in rats.
Topics: Administration, Topical; Adrenal Cortex Hormones; Animals; Atrophy; Betamethasone; Body Weight; Dexamethasone; Disease Models, Animal; Flumethasone; Fluocinolone Acetonide; Fluocinonide; Flurandrenolone; Hydrocortisone; Male; Rats; Skin Diseases; Telangiectasis; Triamcinolone | 1976 |